| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | IDXX Idexx Laboratories Inc /de | Polewaczyk James F66 | Executive Vice President | Sell | 11,636 | $521.79 | $6,071,500.15 | -16.8% | +6.6% | -16.7% | |
| Dec 7, 2023 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 10,000 | $5.22 | $52,200.00 | -6.0% | +79.4% | +45.5% | |
| Dec 7, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 74,852 | $9.19 | $687,889.88 | +0.2% | -0.2% | +111.9% | |
| Dec 7, 2023 | ATR Aptargroup, Inc. | Prieur Marc66 | Segment President | Sell | 3,200 | $126.24 | $403,968.00 | -18.8% | +13.1% | +35.3% | |
| Dec 6, 2023 | NPCE Neuropace Inc | Morrell Martha59 | Chief Medical Officer | Sell | 11,005 | $8.16 | $89,773.29 | -8.0% | +72.7% | +37.2% | |
| Dec 6, 2023 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 6,096 | $39.96 | $243,572.39 | -11.5% | +20.1% | +142.4% | |
| Dec 6, 2023 | DXR Daxor Corp | Michel Robert J61 | Chief Financial Officer | Buy | 120 | $7.75 | $930.00 | +1.2% | -3.1% | +13.7% | |
| Dec 6, 2023 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 3,500 | $70.00 | $245,005.60 | -12.8% | +23.9% | +4.2% | |
| Dec 6, 2023 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 353 | $55.03 | $19,425.59 | -0.6% | +22.3% | +65.1% | |
| Dec 6, 2023 | STAA Staar Surgical Co | Zhou Lilian Yansheng | Director | Buy | 850 | $30.74 | $26,129.00 | +57.5% | +8.8% | -17.5% | |
| Dec 6, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 82,813 | $9.06 | $750,285.78 | +0.2% | +1.8% | +108.2% | |
| Dec 6, 2023 | PRCT Procept Biorobotics Corp | Moll Frederic H | Director | Sell | 79,000 | $38.75 | $3,061,355.08 | -4.6% | +20.1% | +142.4% | |
| Dec 6, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 6,211 | $1.10 | $6,829.98 | - | +17.6% | -42.8% | |
| Dec 5, 2023 | IRTC Irhythm Holdings, Inc. | Murphy Patrick Michael55 | Cbo And CLO | Sell | 1,686 | $88.82 | $149,750.52 | -5.2% | +27.4% | +1.4% | |
| Dec 5, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 66,021 | $9.34 | $616,636.14 | +23.1% | +2.8% | +110.4% | |
| Dec 5, 2023 | TELA Tela Bio, Inc. | Firestone Gregory A. | Chief Business Officer | Buy | 2,600 | $5.65 | $14,688.44 | +7.9% | +27.3% | -47.0% | |
| Dec 5, 2023 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 7,935 | $1.00 | $7,895.33 | -0.8% | +29.5% | +248.4% | |
| Dec 5, 2023 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 26,445 | $0.09 | $2,409.14 | -8.8% | - | - | |
| Dec 5, 2023 | MXCT Maxcyte, Inc. | Doerfler Douglas81 | President And CEO | Sell | 124,450 | $5.14 | $639,405.22 | -15.7% | -10.9% | -30.0% | |
| Dec 5, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 10,000 | $41.77 | $417,677.50 | -2.5% | -0.2% | +30.0% | |
| Dec 4, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 27,000 | $10.38 | $280,260.00 | +10.4% | -5.9% | +97.5% | |
| Dec 4, 2023 | CNMD Conmed Corp | Peters Stanley W III79 | President As And Aet | Sell | 2,300 | $109.93 | $252,833.48 | -97.3% | -25.7% | -32.8% | |
| Dec 4, 2023 | AHCO Adapthealth Corp. | Williams David Solomon III60 | Director | Sell | 2,255 | $9.30 | $20,971.50 | -7.0% | +15.0% | +4.1% | |
| Dec 4, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 1,595 | $1.13 | $1,799.32 | - | +13.0% | -43.6% | |
| Dec 4, 2023 | IDXX Idexx Laboratories Inc /de | Mazelsky Jonathan Jay63 | President And CEO | Sell | 7,128 | $513.05 | $3,657,049.04 | -4.3% | +10.6% | -16.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.